MENS jyongbio.com: Dhuwit awis perusahaan

MENS (Jyong Biotech Corp) - tandha merek perusahaan

Revenue dynamics for Jyong Biotech Ltd (MENS) are based on the commercialization of the botanical agent MCS-2 for the treatment of BPH. Growth relies on the success of clinical trials and patent protection, while the environmental profile is limited to basic waste disposal. Changes in the cash balance demonstrate liquidity for investments, and the 0.00 metric confirms the company's current level of available capital.

MENS - Dana dhuwit perusahaan Jyong Biotech Limited ing rentang 18.06.2025 - 21.11.2026

Ringkesan rincian data analitis Jyong Biotech Corp (MENS)

- kuotasi lan prakiraan analis:
Ringkesan analisis perusahaan:Jyong Biotech Limited
Produk mawa merek Jyong Biotech Limited

For Jyong Biotech Ltd (MENS), the volume of liquid assets determines the ability to fund the expansion of plant-based pharmaceuticals into Asian pharmacy chains without the risk of a cash crunch. An analysis of cash capital levels, reflecting the aggregate of cash and cash equivalents, allows investors to assess the balance between operational resilience and asset utilization efficiency during the business scaling period.

Pesaing Jyong Biotech Ltd (MENS)

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|LGND: Dhuwit awis lan setara dhuwit awis perusahaan|AMRX: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Perrigo Company plc|ALVO: Volume dana dhuwit perusahaan|Liquidia (LQDA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Galapagos N.V.|Dhuwit awis perusahaan ANI Pharmaceuticals, Inc. (ANIP)|Volume dana dhuwit perusahaan MNKD|AMPH (Amphastar Corp) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan pacira.com PCRX|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan